Vivid Wealth Management LLC Sells 247 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Vivid Wealth Management LLC lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.8% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 4,879 shares of the medical equipment provider’s stock after selling 247 shares during the quarter. Intuitive Surgical makes up 1.3% of Vivid Wealth Management LLC’s holdings, making the stock its 26th biggest holding. Vivid Wealth Management LLC’s holdings in Intuitive Surgical were worth $2,547,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical in the fourth quarter worth $26,000. Godsey & Gibb Inc. grew its stake in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. bought a new stake in shares of Intuitive Surgical in the third quarter worth $33,000. Decker Retirement Planning Inc. bought a new stake in shares of Intuitive Surgical in the fourth quarter worth $36,000. Finally, Capital Performance Advisors LLP bought a new stake in shares of Intuitive Surgical in the third quarter worth $38,000. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In related news, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Myriam Curet sold 408 shares of the company’s stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the completion of the sale, the executive vice president now directly owns 353 shares of the company’s stock, valued at $208,181.75. The trade was a 53.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 6,348 shares of company stock worth $3,587,582 in the last quarter. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

ISRG opened at $595.55 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm has a market capitalization of $212.12 billion, a PE ratio of 92.91, a P/E/G ratio of 5.67 and a beta of 1.39. The company’s 50-day moving average is $558.58 and its 200 day moving average is $518.00.

Analysts Set New Price Targets

Several analysts recently weighed in on ISRG shares. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. JPMorgan Chase & Co. boosted their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, Truist Financial boosted their target price on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.